U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 21:33:51 GMT 2025
Edited
by admin
on Mon Mar 31 21:33:51 GMT 2025
Protein Type FUSION PROTEINS
Protein Sub Type
Sequence Type COMPLETE
Record UNII
02E00T2QDE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
eftrenonacog alfa [INN]
Preferred Name English
EFTRENONACOG ALFA
INN   WHO-DD  
INN  
Official Name English
ALPROLIX
Brand Name English
BIIB-029
Code English
BLOOD-COAGULATION FACTOR IX (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT), (421-6'),(424-9')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT)
Common Name English
Eftrenonacog alfa [WHO-DD]
Common Name English
RFIXFC
Common Name English
COAGULATION FACTOR IX RECOMBINANT IMMUNOGLUBULIN G1 FUSION PROTEIN
Common Name English
EFTRENONACOG ALFA [MI]
Common Name English
EFTRENONACOG ALFA [JAN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/07/453
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
EMA ASSESSMENT REPORTS ALPROLIX (AUTHORIZED: HEMOPHILIA B)
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
FDA ORPHAN DRUG 261508
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
Code System Code Type Description
MERCK INDEX
m12110
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
DRUG CENTRAL
5084
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
NCI_THESAURUS
C171659
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
FDA UNII
02E00T2QDE
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
IUPHAR
7373
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
SMS_ID
100000159812
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
EVMPD
SUB170597
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
DAILYMED
02E00T2QDE
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
INN
9660
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
CAS
1270012-74-2
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
DRUG BANK
DB11608
Created by admin on Mon Mar 31 21:33:51 GMT 2025 , Edited by admin on Mon Mar 31 21:33:51 GMT 2025
PRIMARY
From To
1_18 1_23
1_51 1_62
1_56 1_71
1_73 1_82
1_88 1_99
1_95 1_109
1_111 1_124
1_132 1_289
1_206 1_222
1_336 1_350
1_361 1_389
1_421 2_6
1_424 2_9
1_456 1_516
1_562 1_620
2_41 2_101
2_147 2_205
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_157
N 1_167
N 1_492
N 2_77
O 1_53
O 1_61
O 1_159
O 1_169
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_155] SITE_SPECIFIC TYROSINE O-SULFATE 29166358BF
AMINO_ACID_SUBSTITUTION [1_64] SITE_SPECIFIC .BETA.-HYDROXY-L-ASPARTIC ACID, THREO- Z9Q5W0U8VW
AMINO_ACID_SUBSTITUTION [1_7] [1_8] [1_15] [1_17] [1_20] [1_21] [1_26] [1_27] [1_30] [1_33] [1_36] [1_40] SITE_SPECIFIC .GAMMA.-CARBOXYGLUTAMIC ACID 16FQV4RZKL
AMINO_ACID_SUBSTITUTION [1_68] [1_158] SITE_SPECIFIC DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL